Y10S514/00 - CPC Classification

• Y10S514/01 » Ru 486, i.e.Ru 38486, Ru 486-6, mifepristone, mifestone, mifegyne, [11b-[4-[n, n-dimethylamino] phenyl]-17a-[prop-1-ynyl]- 4,9-estradiene-17b-ol-3-one, [11b,17b]11-[4-[dimethylamino]-phenyl]-17-hydroxy-17-[1-propynyl] estra-4,9-dien-3-one] 1
• Y10S514/80 » LHRH like 3
• Y10S514/801 » Collagen, gelatin or derivatives thereof 32
• Y10S514/802 » Fibrinopeptides, blood-coagulation factors or derivatives 22
• Y10S514/803 » Kinin or derivatives 0
• Y10S514/804 » Phecmycin series or derivatives 0
• Y10S514/805 » Adrenocorticotropic hormone or derivatives 1
• Y10S514/806 » Somatostatin or derivatives 11
• Y10S514/807 » Oxytoxin, vasopressin or derivatives 10
• Y10S514/808 » Calcitonin or derivatives 13
• Y10S514/809 » Enkephalin or endorphin or derivatives 3
• Y10S514/81 » Addiction 22
• Y10S514/814 » Anemia 28
• Y10S514/816 » Anesthetic, general 24
• Y10S514/817 » Anesthetic, topical 11
• Y10S514/818 » Anesthetic, local 17
• Y10S514/819 » Antacid, oral 7
• Y10S514/821 » Antiarrhythmic 16
• Y10S514/822 » Anticoagulation 16
• Y10S514/823 » Antidote 8
• Y10S514/824 » Arteriosclerosis 79
• Y10S514/825 » Arthritis 133
• Y10S514/826 » Asthma 151
• Y10S514/827 » Astringent, nonfacial 3
• Y10S514/829 » Bite or sting 6
• Y10S514/832 » Blood substitute 22
• Y10S514/833 » Blood plasma extender 6
• Y10S514/834 » Coagulant 15
• Y10S514/835 » Caries 15
• Y10S514/836 » Chelate 27
• Y10S514/837 » Cholera 4
• Y10S514/838 » Cirrhosis 18
• Y10S514/839 » Contact lens treatment 23
• Y10S514/841 » Contraceptive 20
• Y10S514/844 » Cosmetic, facial 91
• Y10S514/849 » Cough and cold preparation 18
• Y10S514/851 » Cystic fibrosis 39
• Y10S514/852 » Dandruff 10
• Y10S514/853 » Decongestant 19
• Y10S514/857 » Dermatitis 0
• Y10S514/866 » Diabetes 330
• Y10S514/867 » Diarrhea 17
• Y10S514/868 » Distemper 0
• Y10S514/869 » Diuretic 15
• Y10S514/87 » Edema 30
• Y10S514/872 » Emesis, motion sickness-nausea 18
• Y10S514/873 » Emollient 3
• Y10S514/874 » Estrogenic agent, noncontraceptive 10
• Y10S514/875 » Flea control 19
• Y10S514/877 » Gallstone 0
• Y10S514/878 » Geriatrics 10
• Y10S514/88 » Hair treatment, application to head or scalp 48
• Y10S514/882 » Hemorrhoid preparation 6
• Y10S514/883 » Hodgkin's disease 9
• Y10S514/884 » Hypoglycemia 6
• Y10S514/885 » Immune response affecting drug 258
• Y10S514/886 » Inflammation, skin 94
• Y10S514/888 » Influenza 12
• Y10S514/889 » Interferon inducer 2
• Y10S514/89 » Irritant, e.g. tear gas 0
• Y10S514/891 » Kidney stone 9
• Y10S514/892 » Laxative 33
• Y10S514/893 » Liver disorder 48
• Y10S514/895 » Malaria 7
• Y10S514/896 » Measles 0
• Y10S514/898 » Meningitis 2
• Y10S514/899 » Menstrual disorder 25
• Y10S514/8995 » Mouth treatment 0
• Y10S514/903 » Multiple sclerosis 79
• Y10S514/904 » Multiple vitamins 41
• Y10S514/906 » Muscle relaxant 3
• Y10S514/907 » Muscular dystrophy 5
• Y10S514/908 » Leukemia 28
• Y10S514/909 » Obesity 151
• Y10S514/912 » Ophthalmic 234
• Y10S514/916 » Pyretic 0
• Y10S514/917 » Radioactive, anti- 1
• Y10S514/918 » Repellent 3
• Y10S514/921 » Shock 13
• Y10S514/922 » Side effect reduction by incorporation of a second designated ingredient 23
• Y10S514/923 » Sleep aid 51
• Y10S514/924 » Tuberculosis 15
• Y10S514/925 » Ulcer treatment 25
• Y10S514/929 » Vasodilator 22
• Y10S514/93 » Vasoconstrictor, nondecongestant 5
• Y10S514/931 » Veneral disease 13
• Y10S514/935 » Uterine motility 0
• Y10S514/936 » Dmso containing 8
• Y10S514/937 » Dispersion or emulsion 167
• Y10S514/944 » Gel 94
• Y10S514/945 » Foam 71
• Y10S514/946 » Penetrant or absorbent, increases or enhances penetration into subject treated 37
• Y10S514/948 » Solid candy type 0
• Y10S514/949 » Naturally derived clay, e.g. bentonite 1
• Y10S514/95 » Macromolecular, other than synthetic resins 6
• Y10S514/951 » Powders, granules or particles of specified mesh or particle size 98
• Y10S514/953 » Shaped forms adapted for noningestible use other than suppository type, e.g. films, inserts 26
• Y10S514/957 » Vapor emmitting composition 8
• Y10S514/958 » for smoking or inhaling 87
• Y10S514/959 » Breathing gases 15
• Y10S514/96 » Significant, tablet formulation, e.g. designated excipient, disintegrant, glydent or lubricant 85
• Y10S514/962 » Capsule, e.g. gelatin 23
• Y10S514/964 » Sustained or differential release type 77
• Y10S514/966 » Rectal 18
• Y10S514/967 » Vaginal 25
• Y10S514/968 » Urethral 9
• Y10S514/969 » Ointment or salve base 16
• Y10S514/97 » Containing designated ingredient to stabilize an active ingredient 82
• Y10S514/974 » Containing designated ingredient to reduce noxious effects of active ingredient, e.g. taste masking, odor reducing 23
• Y10S514/975 » Characterized by the designated surfactant used 42

Recent Application in this class: